Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H O Heuer

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Lipids|December 1, 1991
Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonistsH O Heuer
Agents and Actions. Supplements|January 1, 1991
The effects of hetrazepine PAF antagonists in preclinical models of asthmaH O Heuer
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 1, 1992
Current status of PAF antagonistsH O Heuer
Journal of Lipid Mediators|July 1, 1991
WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigsH O Heuer
European Journal of Pharmacology|June 25, 1991
Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170)H O Heuer
Lipids|December 1, 1991
Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigsH O Heuer
Journal of Lipid Mediators|November 1, 1991
PAF receptor antagonists influence asphyxia-induced changes of the inner earA Ernst, H O Heuer
Arzneimittel-Forschung|August 1, 1992
Platelet-activating factor antagonists in experimental shockG Muacevic, H O Heuer
Methods in Enzymology|January 1, 1990
Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonistsJ Casals-Stenzel, H O Heuer
Medicinal Research Reviews|April 1, 1989
Hetrazepines as antagonists of platelet activating factorK H Weber, H O Heuer
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Lipids|December 1, 1991
Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonistsH O Heuer
Agents and Actions. Supplements|January 1, 1991
The effects of hetrazepine PAF antagonists in preclinical models of asthmaH O Heuer
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 1, 1992
Current status of PAF antagonistsH O Heuer
Journal of Lipid Mediators|July 1, 1991
WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigsH O Heuer
European Journal of Pharmacology|June 25, 1991
Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170)H O Heuer
Lipids|December 1, 1991
Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigsH O Heuer
Journal of Lipid Mediators|November 1, 1991
PAF receptor antagonists influence asphyxia-induced changes of the inner earA Ernst, H O Heuer
Arzneimittel-Forschung|August 1, 1992
Platelet-activating factor antagonists in experimental shockG Muacevic, H O Heuer
Methods in Enzymology|January 1, 1990
Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonistsJ Casals-Stenzel, H O Heuer
Medicinal Research Reviews|April 1, 1989
Hetrazepines as antagonists of platelet activating factorK H Weber, H O Heuer
Pageof 3